A question of visibility

Cohort (LSE:CHRT), the defence technology group, has told shareholders that much of its current-year Revenue is already under contract. In its Annual General Meeting statement published on 24 September 2026, the company said its order book stood at about £700m in mid-September and covered nearly 90% of current market consensus revenue expectations for the year ending 30 April 2027. That level of cover, rather than any single month's trading, is the most useful measure of how predictable the group's near-term revenue may be.

The board also said trading in the year to date had been consistent with its expectations, and that its outlook for growth in the 2027 financial year was unchanged, with a weighting to the second half as in previous years. These are management statements, not reported results.

The Orka contract

A significant addition to the order book came in August, when German Subsidiary ELAC SONAR won a contract worth €140.7m to work with Saab on integrated sonar systems for Poland's Orka submarine programme. According to the AGM statement, work started immediately and deliveries are scheduled to run to the mid-2030s. The contract is denominated in euros, so its sterling value within the order book can move with exchange rates.

The long delivery profile matters for interpretation. A contract of this length adds to the order book now but contributes revenue over many years, so it lengthens visibility more than it lifts any single year's sales. Management also described Demand from domestic and export customers as healthy. ELAC sits in Cohort's Sensors and Effectors division alongside Chess Dynamics and SEA, while Communications and Intelligence comprises EID, EM Solutions, MASS and MCL.

The starting point from last year

In final results published in July 2026 for the year ended 30 April 2026, Cohort (LSE:CHRT) reported revenue of £306.4m, up 13% from £270.0m, and adjusted operating profit of £36.3m, up from £27.5m. Adjusted Earnings Per Share were 61.9p. Order intake was £314.2m and the closing order book a record £618.8m. The board proposed a final Dividend of 12.10p, and the AGM statement said the total dividend rose 10%.

Comparing those figures with the September statement, the order book appears to have grown by roughly £80m within five months, based on the rounded £700m figure. The shares were about 1390p at the close of the 2 November session.

What the cover does not tell investors

Order cover measured against consensus is a benchmark built on analysts' forecasts, not company guidance, and consensus can change. A high cover ratio also says little about margins, since profitability depends on contract mix, execution and cost inflation. Defence programmes can be delayed by customer decisions, export approvals or Supply chain constraints, which can shift revenue between years even where orders are secure.

The group also relies on second-half delivery, so first-half figures can look weaker in isolation. Funding flexibility was strengthened in April 2026, when the bank Facility was increased to £175m with a further £50m accordion, which management said would support product development, facilities, acquisitions and Working Capital swings. The company has said its medium-term aim is to lift net margins to a mid-teens percentage; that is an ambition, not a forecast, and the September statement did not attach a date to it.

Next steps

Recent filings were routine: the employee benefit trust bought 31,329 shares at £12.592 on 13 October to satisfy employee share awards, taking its holding to 1,112,612 shares. The next disclosed milestone is the half-year results for the six months to 31 October 2026, which the company said would be published in December 2026. Those results should show how much of the order book has converted into revenue and whether intake has continued to build.